Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
2024 · Advances in Rheumatology · 3 citations
https://doi.org/10.1186/s42358-024-00397-5
V
Viviane Angelina de Souza
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
1.2K
Citations
12
h-index
14
i10-index
Viviane Angelina de Souza is an academic researcher from Universidade Federal de Juiz de Fora. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 12, co-authored 91 publications.
ORCID: 0000-0001-6386-3776Papers by this author
worksBrazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases
2025 · Advances in Rheumatology · 3 citations
https://doi.org/10.1186/s42358-025-00449-4
Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortality and disease progression in a six-year prospective cohort
2025 · PLoS ONE · 2 citations
https://doi.org/10.1371/journal.pone.0318773
POS0572 FACTORS ASSOCIATED WITH VACCINE RESPONSE AFTER COVID VACCINE BOOSTER IN PATIENTS WITH AUTOIMMUNE DISEASES: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY
2024 · Annals of the Rheumatic Diseases · 0 citations
https://doi.org/10.1136/annrheumdis-2024-eular.1974
Reply to the letter on “Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?”
2025 · Advances in Rheumatology · 0 citations
https://doi.org/10.1186/s42358-025-00501-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat